KMKeisuke Matsusaka

Keisuke Matsusaka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Keisuke Matsusaka has a total of 95 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Endometriosis-associated lesions during or after long-term estrogen-only therapy following hysterectomy: 2 cases

    by Daisuke Sugimoto, Hiroshi Ishikawa, Miyuki Harada, Natsuho Kaneda, Keisuke Matsusaka, Kaori Koga

    Estrogen-only menopausal hormone therapy (MHT) is prescribed after hysterectomy; however, occult or residual endometriotic tissue may remain hormonally responsive. We report 2 women in whom endometriotic lesions were identified during or after long-term transdermal estrogen-only MHT after hysterectomy and bilateral salpingo-oophorectomy. The first patient was a 48-year-old woman treated for International Federation of Gynecology and Obstetrics 2009 stage IA, grade 1 endometrioid endometrial carcinoma at 44 years of age. Her estrogen-progestogen MHT for treatment-related premature ovarian insufficiency was changed to transdermal estrogen-only MHT. About 3 years later, she developed a progressively enlarging ileocecal mass, with resection revealing endometriosis. The second patient was a 54-year-old woman who had undergone hysterectomy and bilateral salpingo-oophorectomy for endometriosis at 46 years of age. She received transdermal estrogen-only MHT for approximately 6 years and was diagnosed with atypical endometrial hyperplasia in vaginal cuff endometriosis 1 year after estrogen withdrawal. These observations do not establish a causal relationship between estrogen-only MHT and lesion development. Occult disease, residual disease, or iatrogenic implantation remain plausible explanations. Nevertheless, these cases highlight that new abdominal masses or posthysterectomy vaginal bleeding during or after MHT warrant careful evaluation with histopathologic confirmation. MHT should be individualized according to current clinical guidelines.

  • Needle-Based Sampling Strategy for Traceable Fresh-Frozen Tissue Collection From Radical Prostatectomy Specimens

    by Takehiro Ishibashi, Ayumi Fujimoto, Keisuke Matsusaka, Yasutaka Yamada, Junryo Rii, Tomokazu Sazuka, Yusuke Imamura, Shinichi Sakamoto, Kiyotaka Onodera, Jun-Ichiro Ikeda, et al.

  • Preoperative detection of muscle retraction in colorectal ESD using computed tomography–colonography

    by Shutaro Hike, Tetsuro Maruyama, Keisuke Matsusaka, Masaya Uesato, Toru Tochigi, Akira Nakano, Takahiro Arasawa, Shunsuke Kainuma, Takuya Hirosuna, Mayuko Kinoshita, et al.

    Background: Muscle retraction (MR) is a major cause of technical difficulty and perforation during colorectal endoscopic sub‐mucosal dissection (ESD). However, no established method exists for predicting MR preoperatively. This study investigated whether computed tomography–colonography (CTC) can detect MR before ESD. Methods: We retrospectively analysed 69 patients who underwent colorectal ESD without muscular invasion (Validation 1). The serosal‐side appearance of the tumour on CTC was classified into four types—bulge, matchstick, round depression and sharp depression—and compared with endoscopically observed MR (eMR). To validate the findings, 55 surgically resected colorectal cancers without muscular invasion were analysed for pathological MR (pMR) and correlated with the same CTC classification (Validation 2). Logistic regression analyses were performed to identify predictors of MR. Results: In Validation 1, all eMR‐positive lesions (5/5) showed the sharp depression type on CTC, whereas 3 of 64 eMR‐negative lesions did (Fisher's exact test, p < 0.0001). In Validation 2, multivariate logistic regression showed that both the sharp depression type (OR 138, p < 0.0001) and severe sub‐mucosal fibrosis (OR 4453, p = 0.0079) were independent predictors of pMR. Intero‐bserver agreement was almost perfect ( κ = 0.93–0.95). Conclusions: The serosal‐surface appearance of colorectal tumours on CTC, especially the sharp depression type, strongly predicts MR. CTC may serve as a simple, non‐invasive preoperative tool for identifying MR and selecting optimal treatment strategies, including surgery, before colorectal ESD.

  • Open Access

    Differences in Mucosal Permeability Among Patients With Ulcerative Colitis Classified Based on the Colonic Location and Disease Activity

    by Wataru Shiratori, Yuki Ohta, Keisuke Matsusaka, Yuhei Ohyama, Yukiyo Mamiya, Hayato Nakazawa, Satsuki Takahashi, Ryosuke Horio, Chihiro Goto, Michiko Sonoda, et al.

    INTRODUCTION: Factors affecting mucosal permeability (MP) in ulcerative colitis (UC) are largely unknown. We aimed to investigate the difference in MP among patients with UC classified according to the colonic locations and to evaluate the correlations between local MP and endoscopic or histological activity of UC. METHODS: The transepithelial electrical resistance (TER), which is inversely proportional to permeability, of tissue samples from the mucosa of the ascending colon, descending colon, and rectum of patients with UC and healthy individuals (HIs) was measured by using the Ussing chamber. TERs were compared between patients with UC and HIs and evaluated according to colonic locations and disease activity of UC. RESULTS: Thirty-eight patients with UC and 12 HIs were included in this study. Both in HIs and patients with UC, MP tends to be higher in the anal side. TER in the ascending colon was significantly lower in patients with UC than in HIs (45.3 ± 9.0 Ω × cm2 vs 53.5 ± 9.7 Ω × cm2, P = 0.01). The increased permeability in UC was observed also in the descending colon, only when the inflammation involved the location. A significant correlation between TER and endoscopic activity was found in the rectum only (r = −0.49, P = 0.002). There were no significant correlations between TERs and UC histology. DISCUSSION: The MP in the colon differs according to the colonic location. The ascending colon among patients with UC showed disease-specific changes in MP, whereas the MP is increased in proportion to the endoscopic activity in the rectum.


  • The neuroendocrine carcinoma component of gastric mixed adenoneuroendocrine carcinoma could develop with MLH1 deficiency independent of TP53 mutation

    by Rei Hashimoto, Keisuke Matsusaka, Tomoaki Matsumura, Koichi Hayano, Naoya Kato, Hisahiro Matsubara, Jun‐Ichiro Ikeda

  • Open Access

    A case report of duodenal arteriovenous malformation: usefulness of intraoperative indocyanine green angiography for precise identification of the lesion

    by Yoshihiro Kurata, Koichi Hayano, Keisuke Matsusaka, Hisashi Mamiya, Masaya Uesato, Kentaro Murakami, Masayuki Kano, Takeshi Toyozumi, Yasunori Matsumoto, Hiroshi Suito, et al.

    Background: Arteriovenous malformation (AVM) of the gastrointestinal (GI) tract can cause bleeding. The treatment choice for GI tract AVM is surgical resection of the involved bowel segment with complete resection of the nidus. The AVM formed in the duodenum or pancreatic head could also cause gastrointestinal bleeding, and there are several reports of pancreaticoduodenectomy as its treatment. However, if the area of AVM can be accurately identified during surgery, it may be possible to completely resect the AVM while preserving the organ. We report a case of duodenal AVM in a patient successfully treated with a subtotal stomach-preserving duodenal bulb resection using intraoperative indocyanine green (ICG) angiography technique. Case presentation: An 18-year-old man was diagnosed with duodenal AVM after several examinations for anemia and was referred to our hospital for further treatment. Preoperative imaging studies showed that the inflow vessels of this duodenal AVM were the inferior pyloric artery and the superior duodenal artery, and the AVM was localized to the duodenal bulb. Thereafter, stomach-preserving duodenal bulb resection preceded by ligation of the inflow vessels was performed. During the surgery, ICG angiography clearly demonstrated the area, where the nidus was distributed, and a duodenal bulb resection with complete resection of the AVM was successfully performed. There was no recurrence at the 6-month follow-up. Conclusions: Intraoperative ICG angiography was a useful procedure for precise identification of the AVM of the GI tract.


  • DNA and Histone Methylation in Gastric Cancer

    by Keisuke Matsusaka, Atsushi Kaneda

  • DNA methylation accumulation and its predetermination of future cancer phenotypes

    by Atsushi Kaneda, Keisuke Matsusaka, Eiji Sakai, Sayaka Funata

    Aberant DNA methylation is a common epigenomic alteration in carcinogenesis. Comprehensive analyses of DNA methylation have stratified gastrointestinal cancer into several subgroups according to specific DNA methylation accumulation. In gastric cancer, Helicobacter pylori infection is a cause of methylation accumulation in apparently normal mucosa. Epstein–Barr virus infection is another methylation inducer that causes more genome-wide methylation, resulting in the formation of unique epigenotype with extensive methylation. In colorectal carcinogenesis, accumulation of high levels of methylation in combination with BRAF mutation is characteristic of the serrated pathway, but not of the adenoma-carcinoma sequence through conventional adenoma. In a de novo pathway, laterally spreading tumours generate intermediate- and low-methylation epigenotypes, accompanied by different genetic features and different macroscopic morphologies. These methylation epigenotypes, with specific genomic aberrations, are mostly completed by the adenoma stage, and additional molecular aberration, such as TP53 mutation, is suggested to lead to cancer development with the corresponding epigenotype. Accumulation of DNA methylation and formation of the epigenotype is suggested to occur during the early stages of carcinogenesis and predetermines the future cancer type.


  • Factors predictive of inaccurate determination of horizontal extent of intestinal‐type early gastric cancers during endoscopic submucosal dissection: A retrospective analysis

    by Itsuko Asada‐Hirayama, Shinya Kodashima, Osamu Goto, Nobutake Yamamichi, Satoshi Ono, Keiko Niimi, Satoshi Mochizuki, Maki Konno‐Shimizu, Rie Mikami‐Matsuda, Chihiro Minatsuki, et al.

    Background Certain tumor characteristics may pose challenges when endoscopically determining the horizontal extent of early gastric cancers (EGC). In the present study, clinicopathological features related to inaccurate endoscopic evaluation of horizontal extent of intestinal‐type EGC were analyzed. Patients and Methods We analyzed 431 lesions with intestinal‐type EGC treated by endoscopic submucosal dissection (ESD) at our hospital. We focused on whether pretreatment demarcation was accurate by comparing positional relationships between marking dots and tumor edges in resected specimens, and factors related to inaccurate evaluation were analyzed. Gender, age, tumor size, location, circumference, depth, ulceration, macroscopic type, presence of a flat (0‐IIb) component, predominant histological type, mixture of diffuse‐type adenocarcinoma, mixed histology, and use of magnification endoscopy with narrow band imaging were analyzed. Reasons for inaccurate evaluation were also investigated by re‐examining endoscopic images and prepared histological slides. Results Rate of inaccurate evaluation of horizontal extent was 7.4% (32/431 lesions). Multivariate analysis revealed the following significant independent variables contributing to inaccurate endoscopic evaluation: presence of a flat component, large size, and predominant histological findings of moderately differentiated adenocarcinoma. Re‐examination of prepared histological slides of inaccurately evaluated cases revealed a marginal flat spreading area in 28 of the 32 lesions (87.5%). In 14 of the 32 lesions (43.8%), tumor margins were composed of moderately differentiated adenocarcinoma. Conclusions For lesions with a flat component, large lesions, and moderately differentiated adenocarcinoma, determination of the horizontal extent can be challenging in EGC indicated for ESD, even with the best available endoscopic tools.


  • ARID1A expression loss in gastric cancer: pathway-dependent roles with and without Epstein–Barr virus infection and microsatellite instability

    by Hiroyuki Abe, Daichi Maeda, Rumi Hino, Yuya Otake, Maya Isogai, Aya Shinozaki Ushiku, Keisuke Matsusaka, Akiko Kunita, Tetsuo Ushiku, Hiroshi Uozaki, et al.

    The AT-rich interactive domain 1A gene (ARID1A), which encodes one of the subunits in the Switch/Sucrose Nonfermentable chromatin remodeling complex, carries mutations and is responsible for loss of protein expression in gastric carcinoma, particularly with Epstein–Barr virus (EBV) infection and a microsatellite instability-high phenotype. We used immunohistochemistry to investigate the significance of ARID1A loss in 857 gastric carcinoma cases, including 67 EBV(+) and 136 MLH1-lost gastric carcinomas (corresponding to a microsatellite instability-high phenotype). Loss of ARID1A expression was significantly more frequent in EBV(+) (23/67; 34 %) and MLH1-lost (40/136; 29 %) gastric carcinomas than in EBV(−)MLH1-preserved (32/657; 5 %) gastric carcinomas (P < 0.01). Loss of ARID1A correlated with larger tumor size, advanced invasion depth, lymph node metastasis, and poor prognosis in EBV(−)MLH1-preserved gastric carcinoma. A correlation was found only with tumor size and diffuse-type histology in MLH1-lost gastric carcinoma, but no correlation was observed in EBV(+) gastric carcinoma. Loss of ARID1A expression in EBV(+) gastric carcinoma was highly frequent in the early stage of gastric carcinoma, although EBV infection did not cause downregulation of ARID1A: EBV-positive nasopharyngeal carcinomas (n = 8) and lymphomas (n = 15) failed to show loss of ARID1A, and EBV infection did not cause loss of ARID1A in gastric carcinoma cell lines. Taken together, loss of ARID1A may be an early change in carcinogenesis and may precede EBV infection in gastric epithelial cells, while loss of ARID1A promotes cancer progression in gastric cancer cells without EBV infection or loss of MLH1 expression. Loss of ARID1A has different and pathway-dependent roles in gastric carcinoma.